Colorado Bill Preserves Patient Access to Compounded Medical Items

Detected March 17th, 2026

Summary

Colorado bill HB26-1262 aims to preserve patient access to compounded medical items. The bill clarifies conditions under which licensed entities can compound, supply, and obtain compounded drugs and devices, and prohibits the state board of pharmacy from adopting rules more restrictive than federal or state law.

View original document View source feed page

What changed

Colorado Bill HB26-1262, concerning patient access to compounded medical items, clarifies the conditions under which licensed entities can compound, supply, and obtain compounded drugs and devices. It specifies that licensed pharmacies or registered 503B outsourcing facilities may supply these items to licensed healthcare providers, pharmacies, facilities, or organizations, provided the compounding is in accordance with applicable federal and state law. The bill also explicitly prohibits the state board of pharmacy from enacting rules that are more restrictive than existing federal or state regulations concerning drug and device compounding.

This legislation is intended to ensure continued patient access to necessary compounded medications. Regulated entities, including pharmacies and healthcare providers, should review the bill's provisions to ensure their compounding and supply chain practices align with the clarified state and federal requirements. While the bill itself does not impose new direct compliance deadlines, adherence to the outlined conditions is necessary to operate within the scope of the preserved access. The bill also exempts certain compounded drugs and devices from sales and delivery prohibitions if they meet specific legal and regulatory criteria.

What to do next

Review Colorado Bill HB26-1262 for specific provisions on compounding, supply, and administration of compounded drugs and devices.
Ensure all compounding and supply chain activities comply with applicable federal and state laws as outlined in the bill.
Verify that the state board of pharmacy's rules are not more restrictive than federal or state law regarding compounding.

Source document (simplified)

HB26-1262

Patient Access to Compounded Medical Items

| Type | Bill |
| --- | --- |
| Session | 2026 Regular Session |
| Subjects | Health Care & Health Insurance Professions & Occupations |
Concerning preserving patient access to compounded medical items.

Recent Bill (PDF) Recent Fiscal Note (PDF) Bill Summary:

The bill provides that, if the action is undertaken in accordance with applicable federal and state law:

A licensed person may compound a drug or device in the state;
A state-licensed pharmacy or a distribution facility registered with the federal food and drug administration (licensed 503B outsourcing facility) may supply a compounded drug or device to a licensed health-care provider, pharmacy, facility, or organization; and
A licensed health-care provider, pharmacy, facility, or organization may obtain, dispense, or administer a compounded drug or device supplied by a state-licensed pharmacy or a licensed 503B outsourcing facility. In addition, the bill prohibits the state board of pharmacy from adopting rules that are more restrictive than federal or state law regarding the compounding of drugs or devices.

Current law exempts drugs that are intended solely for investigational use by experts qualified by scientific training and experience and that are plainly labeled for investigational use only from the sales and delivery prohibition for new drugs. The bill also exempts from the prohibition:

Drugs that are reviewed by an institutional review board and plainly labeled for investigational use only; and
Compounded drugs and devices if the compounding of the drug or device is undertaken in accordance with applicable federal and state law. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Prime Sponsors

Representative

Katie Stewart
Representative

Rebekah Stewart
Senator

Matt Ball
Senator

Dylan Roberts

Committees

House

Health & Human Services

If you require reasonable accessibility accommodation to access this content, please email accessibility@coleg.gov.

Status

Under Consideration

Introduced

Under Consideration

Related Documents & Information

| Date | Version | Documents |
| --- | --- | --- |
| 03/16/2026 | Reengrossed | PDF |
| 03/13/2026 | Engrossed | PDF |
| 02/19/2026 | Introduced | PDF |

| Date | Version | Documents |
| --- | --- | --- |
| 03/03/2026 | Initial Fiscal Note | PDF |

| Activity | Vote | Documents |
| --- | --- | --- |
| Refer House Bill 26-1262 to the Committee of the Whole. | The motion passed on a vote of 11-2. | Vote summary |
Committee Report: PDF
| Date | Calendar | Motion | Vote | Vote Document |
| --- | --- | --- | --- | --- |
| 03/16/2026 | Third Reading | BILL | 61 AYE 1 NO 3 OTHER | Vote record |
| 03/13/2026 | Committee of the Whole | AMD (H.002) | 19 AYE 40 NO 6 OTHER | Vote record |
| 03/13/2026 | Committee of the Whole | AMD (H.001) | 21 AYE 37 NO 7 OTHER | Vote record |

| Date | Amendment Number | Committee/ Floor Hearing | Status | Documents |
| --- | --- | --- | --- | --- |
| 03/13/2026 | L.001 | Second Reading | Lost [] | PDF |
| 03/13/2026 | L.003 | Second Reading | Lost [] | PDF |
| 03/13/2026 | L.005 | Second Reading | Lost [] | PDF |
| 03/13/2026 | L.006 | Second Reading | Passed [] | PDF |
* Amendments passed in committee are not incorporated into the measure unless adopted by the full House or Senate.

** The status of Second Reading amendments may be subsequently affected by the adoption of an amendment to the Committee of the Whole Report. Refer to the House or Senate Journal for additional information.

| Date | Location | Action |
| --- | --- | --- |
| 03/16/2026 | House | House Third Reading Passed - No Amendments |
| 03/13/2026 | House | House Second Reading Special Order - Passed with Amendments - Floor |
| 03/10/2026 | House | House Committee on Health & Human Services Refer Unamended to House Committee of the Whole |
| 02/19/2026 | House | Introduced In House - Assigned to Health & Human Services |
Prime Sponsor

Rep. K. Stewart | Rep. R. Stewart

Sen. M. Ball | Sen. D. Roberts

Sponsor

(None) Co-Sponsor